HIPEC: HOPE or HYPE in the fight against advanced ovarian cancer?

Ann Oncol. 2018 Aug 1;29(8):1610-1613. doi: 10.1093/annonc/mdy198.

¹ Department of Surgery and Cancer, Gynecologic Oncology, Hammersmith Hospital Imperial College London, London, UK; Department of Gynecology, Charité Medical University of Berlin, Berlin; North-Eastern German Society of Gynaecologic Oncology (NOGGO) Ovarian Cancer Study Group, Taufkirchen, Germany; Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group, Taufkirchen, Germany. Electronic address: c.fotopoulou@imperial.ac.uk.
² Department of Gynecology, Charité Medical University of Berlin, Berlin; North-Eastern German Society of Gynaecologic Oncology (NOGGO) Ovarian Cancer Study Group, Taufkirchen, Germany; Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group, Taufkirchen, Germany.
³ Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group, Taufkirchen, Germany; Department of Obstetrics and Gynecology, Ludwig-Maximilians-University Munich, München, Germany.
⁴ Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group, Taufkirchen, Germany; Department of Gynecology, Kliniken Essen Mitte, Essen, Germany.
⁵ University Hospitals Leuven, Leuven, Belgium; BGOG, Leuven, Belgium.
⁶ Department of Medical Oncology, Clínica Universidad de Navarra, Madrid, Spain; GEICO Study Group, Madrid, Spain.
⁷ GEICO Study Group, Madrid, Spain; Department of Obstetrics and Gynecology, Clínica Universidad de Navarra, Madrid, Spain.

No abstract available

Publication types